Damora Therapeutics Inc 's

• DMRA's Stock Performance relative to its Competitors

Sage Therapeutics Inc Share Performance -20.73% One Year

Sage Therapeutics Inc Profile Sage Therapeutics Inc's business model primarily revolves around researching, developing, and commercializing innovative therapies for various central nervous system disorders. The company focuses on discovering novel molecules and applying them to create targeted treatments that address the unmet medical needs of patients. By harnessing scientific advancements and strategic collaborations, Sage aims to deliver transformative therapies for individuals suffering from conditions such as depression, postpartum depression, and other mood disorders. More about Sage Therapeutics Inc 's Market Share

Pliant Therapeutics Inc Share Performance -1.69% This Quarter

Pliant Therapeutics Inc Profile Pliant Therapeutics Inc operates with a business model focused on developing novel therapeutics to address fibrotic diseases. The company conducts extensive research to identify and target specific molecular pathways involved in fibrosis, with the aim of developing effective treatments. Pliant Therapeutics collaborates with academic institutions and conducts preclinical and clinical studies to bring its products to market and improve the lives of patients suffering from fibrotic conditions. More about Pliant Therapeutics Inc 's Market Share

Nektar Therapeutics Share Performance +1.01% 30 Days

Nektar Therapeutics Profile Nektar Therapeutics operates under a business model focused on developing and commercializing innovative medicines. The company's approach involves utilizing its proprietary technology platforms to create novel therapeutic candidates and establish partnerships with pharmaceutical and biotechnology firms for clinical development and commercialization. Nektar Therapeutics aims to bring transformative therapies to market that address significant unmet medical needs. More about Nektar Therapeutics's Market Share

Cytokinetics Incorporated Share Performance +37.18% One Year

Cytokinetics Incorporated Profile Cytokinetics Incorporated is a biopharmaceutical company with a business model centered around the discovery and development of novel muscle activators. They strive to improve the lives of patients with debilitating diseases by focusing on the development of potentially life-changing therapies. Cytokinetics aims to achieve commercial success by leveraging its expertise in muscle biology and utilizing strategic collaborations to bring their innovative therapies to market. More about Cytokinetics Incorporated's Market Share

Mannkind Corporation Share Performance +20.83% This Quarter

Mannkind Corporation Profile MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of inhaled therapeutic solutions for patients with diseases such as diabetes and pulmonary arterial hypertension. The company's business model revolves around conducting research and development to create innovative inhalation therapies and gaining regulatory approvals for these treatments. They then market and distribute their products, either directly or through partnerships, to healthcare providers and patients worldwide. More about Mannkind Corporation's Market Share

Sources: Damora Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 5, 2026 7:09 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Damora Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.